Correlates of serum leptin and insulin-like growth factor-I concentrations in normal weight and overweight/obese Iranian women

Journal of Women's Health

Volumn 17, Issue 8, 2008, Pages 1389-1397

  Ostadrahimi, Alireza ^a   Moradi, Tala ^a   Zarghami, Nosratollah ^a   Shoja, Mohammadali M ^a  

^a UNIVERSITY OF TABRIZ   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

LEPTIN; SOMATOMEDIN C;

ADULT; ANTHROPOMETRY; ARTICLE; BODY FAT; BODY MASS; BODY WEIGHT; CONTROLLED STUDY; CORRELATION COEFFICIENT; DOUBLE ANTIBODY SANDWICH ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GROUPS BY AGE; HUMAN; MAJOR CLINICAL STUDY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OBESITY; PREMENOPAUSE; PRIORITY JOURNAL; RANK SUM TEST; WAIST HIP RATIO;

ADULT; ANTHROPOMETRY; BODY FAT DISTRIBUTION; BODY MASS INDEX; BODY WEIGHT; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; IRAN; LEPTIN; LINEAR MODELS; MIDDLE AGED; OVERWEIGHT; WAIST-HIP RATIO;

EID: 52749093270     PISSN: 15409996     EISSN: None     Source Type: Journal    
DOI: 10.1089/jwh.2007.0736     Document Type: Article

References (49)

1. Burchardt P, Gozdzicka-Jozefiak A, Siminiak T. IGF-I - A new risk factor for coronary atherosclerosis. Kardiol Pol 2006;64:1297-1302.
2. Ruotolo G, Bavenholm P, Brismar K, et al. Serum insulin-like growth factor-I level is independently associated with coronary artery disease progression in young male survivors of myocardial infarction: Beneficial effects of bezafibrate treatment. J Am Coll Cardiol 2000;35:647-654.
3. Fischer F, Schulte H, Mohan S, et al. Associations of insulin-like growth factors, insulin-like growth factor binding proteins and acid-labile subunit with coronary heart disease. Clin Endocrinol (Oxf) 2004;61:595-602.
4. Wolk R, Berger P, Lennon RJ, Brilakis ES, Johnson BD, Somers VK. Plasma leptin and prognosis in patients with established coronary atherosclerosis. J Am Coll Cardiol 2004;44:1819-1824.
5. Reilly MP, Iqbal N, Schutta M, et al. Plasma leptin levels are associated with coronary atherosclerosis in type 2 diabetes. J Clin Endocrinol Metab 2004;89:3872-3878.
6. Soderberg S, Ahren B, Eliasson M, Dinesen B, Brismar K, Olsson T. Circulating IGF binding protein-1 is inversely associated with leptin in non-obese men and obese postmenopausal women. Eur J Endocrinol 2001;144:283-290.
7. Gomez JM, Maravall FJ, Gomez N, Navarro MA, Casamitjana R, Soler J. Interactions between serum leptin, the insulin-like growth factor-I system, and sex, age, anthropometric and body composition variables in a healthy population randomly selected. Clin Endocrinol (Oxf) 2003;58:213-219.
8. Fried SK, Ricci MR, Russell CD, Laferrere B. Regulation of leptin production in humans. J Nutr 2000;130:3127S-3131S.
9. Gorden P, Gavrilova O. The clinical uses of leptin. Curr Opin Pharmacol 2003;3:655-659.
10. Considine RV, Sinha MK, Heiman ML, et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 1996;334:292-295.
11. Gregoire Nyomba BL, Johnson M, Berard L, Murphy LJ. Relationship between serum leptin and the insulin-like growth factor-I system in humans. Metabolism 1999;48:840-844.
12. Tannenbaum GS, Gurd W, Lapointe M. Leptin is a potent stimulator of spontaneous pulsatile growth hormone (GH) secretion and the GH response to GH-releasing hormone. Endocrinology 1998;139:3871-3875.
13. Fors H, Matsuoka H, Bosaeus I, Rosberg S, Wikland KA, Bjarnason R. Serum leptin levels correlate with growth hormone secretion and body fat in children. J Clin Endocrinol Metab 1999;84:3586-3590.
14. Pantsulaia I, Trofimov S, Kobyliansky E, Livshits G. Genetic regulation of the variation of circulating insulin-like growth factors and leptin in human pedigrees. Metabolism 2005;54:975-981.
15. Kajantie E, Fall CH, Seppala M, et al. Serum insulin-like growth factor (IGF)-I and IGF-binding protein-1 in elderly people: Relationships with cardiovascular risk factors, body composition, size at birth, and childhood growth. J Clin Endocrinol Metab 2003;88:1059-1065.
16. Rosen CJ. Serum insulin-like growth factors and insulin-like growth factor-binding proteins: Clinical implications. Clin Chem 1999;45:1384-1390.
17. Prolo P, Wong ML, Licinio J. Leptin. Int J Biochem Cell Biol 1998;30:1285-1290.
18. De Marinis L, Bianchi A, Mancini A, et al. Growth hormone secretion and leptin in morbid obesity before and after biliopancreatic diversion: Relationships with insulin and body composition. J Clin Endocrinol Metab 2004;89:174-180.
19. Schoen RE, Schragin J, Weissfeld JL, et al. Lack of association between adipose tissue distribution and IGF-I and IGFBP-3 in men and women. Cancer Epidemiol Biomarkers Prev 2002;11:581-586.
20. Luke AH, Rotimi CN, Cooper RS, et al. Leptin and body composition of Nigerians, Jamaicans, and U.S. blacks. Am J Clin Nutr 1998;67:391-396.
21. Attia N, Tamborlane WV, Heptulla R, et al. The metabolic syndrome and insulin-like growth factor I regulation in adolescent obesity. J Clin Endocrinol Metab 1998;83:1467-1471.
22. Bahrami H, Sadatsafavi M, Pourshams A, et al. Obesity and hypertension in an Iranian cohort study: Iranian women experience higher rates of obesity and hypertension than American women. BMC Public Health 2006;6:158.
23. Maddah M. Overweight and obesity among Iranian female adolescents in Rasht: More overweight in the lower social group. Public Health Nutr 2007;10:450-453.
24. Ayatollahi SM, Carpenter RG. Height, weight, BMI and weight-for-height of adults in southern Iran: How should obesity be defined? Ann Hum Biol 1993;20:13-19.
25. Mahan LK, Escott-Stump S. Krause's Food, nutrition and diet therapy, 11th ed. Philadelphia, PA: Saunders, 2004.
26. Meyers LS, Gamst G, Guarino AJ. Applied multivariate research: Design and interpretation. Thousand Oaks, California: Sage Publisher, 2006.
27. Marshall JA, Grunwald GK, Donahoo WT, Scarbro S, Shetterly SM. Percent body fat and lean mass explain the gender difference in leptin: Analysis and interpretation of leptin in Hispanic and non-Hispanic white adults. Obes Res 2000;8:543-552.
28. Peltz G, Sanderson M, PÇrez A, Sexton K, Ochoa Casares D, Fadden MK. Serum leptin concentration, adiposity, and body fat distribution in Mexican-Americans. Arch Med Res 2007;38:563-570.
29. Probst-Hensch NM, Yuan JM, Stanczyk FZ, Gao YT, Ross RK, Yu MC. IGF-1, IGF-2 and IGFBP-3 in prediagnostic serum: Association with colorectal cancer in a cohort of Chinese men in Shanghai. Br J Cancer 2001;85:1695-1699.
30. Teramukai S, Rohan T, Eguchi H, Oda T, Shinchi K, Kono S. Anthropometric and behavioral correlates of insulin-like growth factor I and insulin-like growth factor binding protein 3 in middle-aged Japanese men. Am J Epidemiol 2002;156:344-348.
31. Tiryakiog[c]lu O, Kadiolgu P, Canerolgu NU, Hatemi H. Age dependency of serum insulin-like growth factor (IGF)-1 in healthy Turkish adolescents and adults. Indian J Med Sci 2003;57:543-548.
32. Kaklamani VG, Linos A, Kaklamani E, Markaki I, Mantzoros C. Age, sex, and smoking are predictors of circulating insulin-like growth factor 1 and insulin-like growth factorbinding protein 3. J Clin Oncol 1999;17:813-817.
33. Goodman-Gruen D, Barrett-Connor E. Epidemiology of insulin-like growth factor-I in elderly men and women. The Rancho Bernardo Study. Am J Epidemiol 1997;145:970-976.
34. Lukanova A, Toniolo P, Akhmedkhanov A, et al. A cross-sectional study of IGF-I determinants in women. Eur J Cancer Prev 2001;10:443-452.
35. Copeland KC, Colletti RB, Devlin JT, McAuliffe TL. The relationship between insulin-like growth factor-I, adiposity, and aging. Metabolism 1990;39:584-587.
36. Bagg W, Aoina J, Cross PA, et al Serum IGF-I levels are similar in Samoan, Maori and European populations despite differences in body composition. Growth Horm IGF Res 2006;16:57-60.
37. Morimoto LM, Newcomb PA, White E, Bigler J, Potter JD. Variation in plasma insulin-like growth factor-1 and insulin-like growth factor binding protein-3: Personal and lifestyle factors (United States). Cancer Causes Control 2005;16:917-927.
38. Henderson KD, Goran MI, Kolonel LN, Henderson BE, Le Marchand L. Ethnic disparity in the relationship between obesity and plasma insulin-like growth factors: The multi-ethnic cohort. Cancer Epidemiol Biomarkers Prev 2006;15:2298-2302.
39. Landin-Wilhelmsen K, Wilhelmsen L, Lappas G, et al. Serum insulin-like growth factor I in a random population sample of men and women: Relation to age, sex, smoking habits, coffee consumption and physical activity, blood pressure and concentrations of plasma lipids, fibrinogen, parathyroid hormone and osteocalcin. Clin Endocrinol (Oxf) 1994; 41:351-357.
40. Zhao HY, Liu JM, Ning G, et al. Relationships between insulin-like growth factor-I (IGF-I) and OPG, RANKL, bone mineral density in healthy Chinese women. Osteoporos Int 2008;19:221-226.
41. Thomas T, Burguera B, Melton LJ 3rd, et al. Relationship of serum leptin levels with body composition and sex steroid and insulin levels in men and women. Metabolism 2000;49:1278-1284.
42. Ryan AS, Elahi D. The effects of acute hyperglycemia and hyperinsulinemia on plasma leptin levels: Its relationships with body fat, visceral adiposity, and age in women. J Clin Endocrinol Metab 1996;81:4433-4438.
43. Ostlund RE Jr, Yang JW, Klein S, Gingerich R. Relation between plasma leptin concentration and body fat, gender, diet, age, and metabolic covariates. J Clin Endocrinol Metab 1996;81:3909-3913.
44. Park KG, Park KS, Kim MJ, et al. Relationship between serum adiponectin and leptin concentrations and body fat distribution. Diabetes Res Clin Pract 2004;63:135-142.
45. Florkowski CM, Collier GR, Zimmet PZ, Livesey JH, Espiner EA, Donald RA. Low-dose growth hormone replacement lowers plasma leptin and fat stores without affecting body mass index in adults with growth hormone deficiency. Clin Endocrinol (Oxf) 1996;45:769-773.
46. Bianda TL, Glatz Y, Boeni-Schnetzler M, Froesch ER, Schmid C. Effects of growth hormone (GH) and insulin-like growth factor-I on serum leptin in GH-deficient adults. Diabetologia 1997;40:363-364.
47. Boni-Schnetzler M, Hauri C, Zapf J. Leptin is suppressed during infusion of recombinant human insulin-like growth factor I (rhIGF I) in normal rats. Diabetologia 1999;42:160-166.
48. Seck T, Englaro P, Blum WF, et al. Leptin concentrations in serum from a randomly recruited sample of 50- to 80-year-old men and women: Positive association with plasma insulin-like growth factors (IGFs) and IGF-binding protein-3 in lean, but not in obese, individuals. Eur J Endocrinol 1998;138:70-75.
49. Grinspoon S, Gulick T, Askari H, et al. Serum leptin levels in women with anorexia nervosa. J Clin Endocrinol Metab 1996;81:3861-3863.